Login / Signup

Commentary on "Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism": A new role for plasminogen activator inhibitor-1-An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity.

Johann Wojta
Published in: Journal of thrombosis and haemostasis : JTH (2022)
Keyphrases
  • venous thromboembolism
  • current status
  • metabolic syndrome
  • insulin resistance
  • type diabetes
  • cardiovascular disease
  • weight loss
  • atrial fibrillation
  • direct oral anticoagulants
  • weight gain
  • skeletal muscle